Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00037791
What this trial is testing

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Who this might be right for
NeoplasmsThrombocytopeniaMultiple Myeloma+1 more
Pfizer 180
Testing effectiveness (Phase 2)Looking for participantsNCT07509086
What this trial is testing

IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia

Who this might be right for
Relapsed/Refractory Multiple MyelomaPlasma Cell Leukemia (PCL)
The First Hospital of Jilin University 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07740486
What this trial is testing

A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease

Who this might be right for
Multiple Myeloma (MM)
Polish Myeloma Consortium 248
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Early research (Phase 1)Study completedNCT03018223
What this trial is testing

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Who this might be right for
Non-Hodgkin's LymphomaAcute Leukemia in RemissionChronic Myeloid Leukemia+5 more
H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Study completedNCT00784823
What this trial is testing

Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 32
Early research (Phase 1)Ended earlyNCT02978235
What this trial is testing

A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma

Who this might be right for
Multiple MyelomaNonHodgkin Lymphoma
Taiho Oncology, Inc. 11
Not applicableLooking for participantsNCT06895291
What this trial is testing

Whole Body MRI in Oncology

Who this might be right for
LymphomaAdvanced Prostate CancerAdvanced Breast Cancer+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,000
Early research (Phase 1)Study completedNCT06082596
What this trial is testing

Study of BEBT-908 in Subjects With Advanced Hematological Tumors

Who this might be right for
Relapsed or Refractory Non-Hodgkin's LymphomaRelapsed or Refractory Multiple Myeloma
BeBetter Med Inc 32
Very early researchNot Yet RecruitingNCT04670055
What this trial is testing

Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Zhejiang University 50
Not applicableLooking for participantsNCT06474182
What this trial is testing

Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma

Who this might be right for
Multiple MyelomaTotal Knee Replacement
Centre Hospitalier Universitaire de Saint Etienne 36
Early research (Phase 1)Study completedNCT04772989
What this trial is testing

Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more
Arcus Biosciences, Inc. 94
Testing effectiveness (Phase 2)Ended earlyNCT01653418
What this trial is testing

Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 10
Post-approval studies (Phase 4)UnknownNCT01249690
What this trial is testing

Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Second Military Medical University 100
Very early researchNot Yet RecruitingNCT07185490
What this trial is testing

IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Plasma Cell Leukemia (PCL)
Institute of Hematology & Blood Diseases Hospital, China 40
Large-scale testing (Phase 3)Study completedNCT01191060
What this trial is testing

Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years

Who this might be right for
Myeloma
University Hospital, Toulouse 700
Testing effectiveness (Phase 2)WithdrawnNCT02628704
What this trial is testing

Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT01746849
What this trial is testing

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaMultiple MyelomaMyelodysplastic Syndrome+1 more
Memorial Sloan Kettering Cancer Center 82
Testing effectiveness (Phase 2)Study completedNCT00002810
What this trial is testing

High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Temple University
Early research (Phase 1)Study completedNCT01526096
What this trial is testing

Stem Cell Transplantation for Patients With Multiple Myeloma

Who this might be right for
Myeloma
University of Chicago 30
Next Page